Péter Ábrányi-Balogh
research fellow
Email: abranyi-balogh.peter
ttk
mta
hu
Phone: +36 1 3826 961
Scientific interests: chemical probes, covalent labelling of proteins, antibody-conjugates, new multicomponent reactions, beta-carboline and isoquinoline alkaloids, reaction mechanisms, organophosphorous compounds
Selected publications
- Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
Douangamath, A.; Fearon, D.; Gehrtz, P.; Krojer, T.; Lukacik, P.; Owen, C. D.; Resnick, E.; Strain-Damerell, C.; Aimon, A.; Ábrányi-Balogh, P.; Brandaõ-Neto, J.; Carbery, A.; Davison, G.; Dias, A.; Downes, T. D.; Dunnett, L.; Fairhead, M.; Firth, J. D.; Jones, S. P.; Keeley, A.; Keserű, G. M.; Klein, H. F.; Martin, M. P.; Noble, M. E. M.; O’Brien, P.; Powell, A.; Reddi, R.; Skyner, R.; Snee, M.; Waring, M. J.; Wild, C.; London, N.; von Delft, F.; Walsh, M. A.
bioRxiv, 2020, 2020.05.27.118117, accepted to Nature Communications - Covalent fragment libraries in drug discovery
Aaron Keeley, László Petri, Péter Ábrányi-Balogh, György M.Keserű
Drug Discovery Today, 2020, 25 (6), 983-996. - A road map for prioritizing warheads for cysteine targeting covalent inhibitors
Péter Ábrányi-Balogh, László Petri, Tímea Imre, Péter Szijj, Andrea Scarpino, Martina Hrast, Ana Mitrović, Urša Pečar Fonovič, Krisztina Németh, Hélène Barreteau, David I. Roper, Kata Horváti, György G.Ferenczy, Janko Kos, Janez Ilaš, Stanislav Gobec, György M.Keserű
European Journal of Medicinal Chemistry, 2018, 160, 94-107. - Design and characterization of a heterocyclic electrophilic fragment library for the discovery of cysteine-targeted covalent inhibitors
Aaron Keeley, Peter Abranyi-Balogh and George M Keserű
MedChemComm, 2019, 10, 263-267. - Synthesis and fluorescent properties of boroisoquinolines, a new family of fluorophores
Dénes Sóvári, Attila Kormos, Orsolya Demeter, András Dancsó, György Miklós Keserű, Mátyás Milen and Péter Ábrányi-Balogh
RSC Advances, 2018, 8, 38598-38605.